Russian Developer of COVID Drug Areplivir Discussing Deliveries to Latin America, Africa

© Sputnik / Maksim Blinov / Go to the mediabankCOVID Drug Areplivir
COVID Drug Areplivir - Sputnik International
MOSCOW (Sputnik) - Russian pharmaceutical company Promomed is in talks with neighbouring countries, Latin America, and Africa to supply them with Areplivir drug that can help in the COVID-19 treatment, the director-general of the company, Andrey Mladentsev, said.

"We are in talks about the delivery of the medication to the countries of Latin America, such as Mexico, South Africa and Commonwealth of Independent States," Mladentsev said.

According to Mladentsev, Areplivir will be available in internet pharmacies in Russia on Saturday and may appear on the shelves of regular pharmacies in Moscow on Monday.

"The recommended price is 12,320 rubles [$164]," he said.

According to the company's head, the price is unlikely to change significantly in the near future.

Areplivir was approved by the Russian Health Ministry in late June.

To participate in the discussion
log in or register
Заголовок открываемого материала